Brian Cooley
« Khutlela Sehlopheng
Motlatsi oa Moporesidente e Moholo, Khokahano ea Khoebo le Ntlafatso ea Lithethefatsi ea Lymphatic BU
- Lilemo tse 30+ tsa boiphihlelo indastering ea biopharmaceutical le saense ea bophelo
- Mong. Cooley o ile a tšoara maemo a fapa-fapaneng a ho rekisa, a ho bapatsa le a boetapele ba khoebo lik'hamphaning tse 500 tse ruileng mme o etelletse pele ho bokella chelete le ho qala boiteko ba lik'hamphani tsa theknoloji ea tlhokomelo ea bophelo.
- Pele a kenella Sorrento, Monghali Cooley o ile a etella pele boiteko ba ho qala lihlahisoa tse ncha lefatšeng ka bophara ka boikarabello ba P&L ho Eli Lilly le Company le Genentech libakeng tsa mafu ho kenyelletsa lefu la tsoekere, Neurology, Immunology le Rare Disease.
- Ho feta moo, o boetse a etelletse pele boiteko ba bohlokoa ba BD, ho fana ka tumello, le ho kopanya machaba le US Sena se kenyelelitse litumellano tse ngata tsa katoloso ea khoebo Europe, Middle East le Afrika, le tumellano ea tšebelisano ea $ 400MM ea ho fana ka tumello, ho nts'etsapele le ho etsa khoebo. agonist ea pele ea GLP-1
- Haufinyane tjena, Monghali Cooley e ne e le CBO bakeng sa Setsi sa Khoebo sa Sofusa se Kimberly-Clark 'me a etella pele boiteko bo atlehileng ba ho rekisa le ho kopanya. Sorrento Therapeutics. O ntse a tsoela pele ho etella pele karolo ea Lymphatic Drug Delivery system ho Sorrento.
- BS